SLNNasdaq United Kingdom
Market cap
$559.260 M
$11.95 +1.96%
Close of 7 Aug 2026
Revenue
$559.0K
#3550 by revenue
Earnings
-$88.6M
Loss-making
Shares outstanding
141,703,840
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Silence Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.